The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,N-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-3-pyridyl]imidazo[1,2-a]pyrazin-3-yl]benzamide ID: ALA3732464
PubChem CID: 117769367
Max Phase: Preclinical
Molecular Formula: C25H27N7O
Molecular Weight: 441.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCN(c2ccc(-c3cn4c(-c5ccc(C(=O)N(C)C)cc5)cnc4cn3)cn2)CC1
Standard InChI: InChI=1S/C25H27N7O/c1-29(2)25(33)19-6-4-18(5-7-19)22-15-28-24-16-26-21(17-32(22)24)20-8-9-23(27-14-20)31-12-10-30(3)11-13-31/h4-9,14-17H,10-13H2,1-3H3
Standard InChI Key: FRHIGJMOBUQTJW-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6168 1.4950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6203 2.9951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9210 3.7422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.2184 2.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2150 1.4893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9143 0.7422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5198 3.7367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.5256 5.2368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8275 5.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1237 5.2268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.1179 3.7268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8160 2.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1749 2.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2517 3.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8114 5.1995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2965 5.4106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2218 4.2301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6621 2.8384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8593 6.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3455 7.0110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1207 7.7476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7956 8.1234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0842 6.0653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.1652 5.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
9 22 1 0
25 28 1 0
28 29 1 0
28 30 2 0
29 31 1 0
29 32 1 0
19 33 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 441.54Molecular Weight (Monoisotopic): 441.2277AlogP: 2.91#Rotatable Bonds: 4Polar Surface Area: 69.87Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.47CX LogP: 1.77CX LogD: 1.44Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.72
References 1. (2014) Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5,